RUNX2 may suppress apoptosis in the presence of functional p53 tumor suppressor and repress the expression of the p53-target gene, p21WAF1, which product inactivates G1/S- and S-cyclin dependent kinases, stopping the cell cycle [19,23]. The gene discussed is TP53; the disease is neoplasm.